ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES?

V. Almadana Pacheco (Sevilla, Spain), C. Benito Bernáldez (Sevilla, Spain), L. Marín Barrera (Sevilla, Spain), R. Ayerbe García (Sevilla, Spain)

Source: Virtual Congress 2020 – COPD phenotypes
Session: COPD phenotypes
Session type: E-poster session
Number: 2432
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Almadana Pacheco (Sevilla, Spain), C. Benito Bernáldez (Sevilla, Spain), L. Marín Barrera (Sevilla, Spain), R. Ayerbe García (Sevilla, Spain). ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES?. 2432

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD DIAGNOSIS: DIFFERENCES ACCORDING GENDER
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


PRESERVED FORCED VITAL CAPACITY IS NOT ALWAYS REPRESENTING EARLY IPF
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017


NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS
Source: International Congress 2019 – Exploring exercise responses in respiratory diseases
Year: 2019


DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD?
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020

RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


ASSOCIATION BETWEEN NEUTROPHIL AND PLATELET TO LYMPHOCYTE RATIO AND DISEASE SEVERITY IN STABLE COPD
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


BODY COMPOSITION ALTERATIONS AND ENDOTHELIAL DYSFUNCTION IN COPD AND HF.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020


OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


SERUM ?-2-MICROGLOBULIN CORRELATES WITH COPD OUTCOMES AND PREDICTS FUTURE HOSPITALIZATION.
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


COMORBIDITIES AND EXERCISE CAPACITY IN PATIENTS WITH OSTRUCTIVE SLEEP APNOEA
Source: International Congress 2019 – Innovations in care for chronic respiratory conditions
Year: 2019


COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



EVALUATION OF SYSTEMATIC INFLAMMATION, OXIDATIVE STRESS AND ENDOTHELIAL DISFUNCTION IN COPD, ASTHMATIC AND ACO PATIENTS WITH OBESITY.
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


PLASMA/SALIVA AND GENOTYPIC/PHENOTYPIC DIFFERENCES OF NICOTINE METABOLITE RATIO.
Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics
Year: 2018



SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017